(Q34632947)

3 August 2017

1 reference

title

Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? (English)

1 reference

adult-onset Still's disease

3 August 2017

1 reference

1 reference

Petros Efthimiou

1

1 reference

3 August 2017

Apostolos Kontzias

series ordinal

2

1 reference

3 August 2017

Carla M Ward

series ordinal

3

1 reference

3 August 2017

Neeta S Ogden

series ordinal

4

1 reference

3 August 2017

publication date

1 June 2007

1 reference

Nature Clinical Practice Rheumatology

3 August 2017

published in

1 reference

3 August 2017

volume

3

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

328-335

1 reference

Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

Still's disease in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Diagnosis and management of adult onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult Still's disease and respiratory failure in a 74 year old woman

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult Still's disease associated with acute human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult Still's disease associated with Mycoplasma pneumoniae infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult onset Still's disease and viral infections

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult-onset Still's disease. Disease course and HLA associations

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

HLA-Bw35 and prognosis in adult Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Type 1 and type 2: a fundamental dichotomy for all T-cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

1 reference

7 January 2021

Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Association between adult-onset Still's disease and interleukin-18 gene polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Blocking IL-1 in systemic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Adult-onset Still's disease. Clinical course and outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

[Treatment of Still disease in adults with intravenous immunoglobulins].

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Longterm outcome of TNF blockade in adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Etanercept in the treatment of adult patients with Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Rapid responses to anakinra in patients with refractory adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0510

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0510

1 reference

3 August 2017

1 reference